Search research articles
Contact Us
Filters
Showing results (51-60 of 82) with videos related to
Page
of 9
Sort By:
Current Research in Translational Medicine
|
April 8, 2018
Celyad's novel CAR T-cell therapy for solid malignancies
Caroline Lonez, Alain Hendlisz, Leila Shaza, et al.
Future Oncology (London, England)
|
June 13, 2022
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, et al.
Targeted Oncology
|
November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
Jean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.
NPJ Breast Cancer
|
December 19, 2020
Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
Ali Bohlok, Peter Vermeulen, Sophia Leduc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2023
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant
Ramsha Iqbal, Maqsood Yaqub, Huseyyin O Bektas, et al.
NPJ Breast Cancer
|
July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
NPJ Breast Cancer
|
July 8, 2017
The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group
Marion Maetens, David Brown, Alexandre Irrthum, et al.
Targeted Oncology
|
November 19, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial
Céleste Lebbé, Antoine Italiano, Nadine Houédé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2017
Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
The Lancet. Oncology
|
July 2, 2019
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Udai Banerji, Carla M L van Herpen, Cristina Saura, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 82) with videos related to
Sort By:
Page
of 9
Current Research in Translational Medicine
|
April 8, 2018
Celyad's novel CAR T-cell therapy for solid malignancies
Caroline Lonez, Alain Hendlisz, Leila Shaza, et al.
Future Oncology (London, England)
|
June 13, 2022
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast
Elisa Agostinetto, Guilherme Nader-Marta, Marianne Paesmans, et al.
Targeted Oncology
|
November 10, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
Jean-Pierre Delord, Antoine Italiano, Ahmad Awada, et al.
NPJ Breast Cancer
|
December 19, 2020
Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients
Ali Bohlok, Peter Vermeulen, Sophia Leduc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2023
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant
Ramsha Iqbal, Maqsood Yaqub, Huseyyin O Bektas, et al.
NPJ Breast Cancer
|
July 20, 2022
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
Elisa Agostinetto, Lieveke Ameye, Samuel Martel, et al.
NPJ Breast Cancer
|
July 8, 2017
The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group
Marion Maetens, David Brown, Alexandre Irrthum, et al.
Targeted Oncology
|
November 19, 2020
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial
Céleste Lebbé, Antoine Italiano, Nadine Houédé, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2017
Phase I Dose-Escalation Study of the Anti-CD70 Antibody ARGX-110 in Advanced Malignancies
Philippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
The Lancet. Oncology
|
July 2, 2019
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Udai Banerji, Carla M L van Herpen, Cristina Saura, et al.
Page
of 9